Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

3i Group PLC In Talks To Sell Pharma Firm Xellia-Reuters


Thursday, 25 Apr 2013 10:56am EDT 

Reuters reported that 3i Group PLC is in discussions to sell pharmaceutical company Xellia which could fetch around EUR750 million ($974.66 million). Linklaters is acting as legal adviser to 3i. A 3i spokesperson was not available for comment. Linklaters did not immediately return a request for comment. 

Company Quote

444.0
5.0 +1.14%
28 Nov 2014